The presence of losses at 17p (TP53), 15q (MGA), and gains at 2p (MYCN, REL) and the lack of 13q14.3 deletions targeting MIR15/MIR16 appeared linked with a higher risk of transformation to Richter syndrome from CLL (33). Here, TP53 is linked to Richter syndrome.